We don't know whether the most recent response to this request contains information or not – if you are Joanna Rodgers please sign in and let everyone know.

Age range and sex distribution of patients with thrombo-embolic events with concurrent thrombocytopenia cases post second dose AZ vaccine

We're waiting for Joanna Rodgers to read recent responses and update the status.

Dear Medicines and Healthcare products Regulatory Agency,

Please provide clarity on the age range and sex distribution of the patients who have been registered as having CVST or other thrombosis-related events with concurrent thrombocytopenia after second vaccination with COV-19 AstraZeneca (Vaxzevria). Please also include fatalities

It would be helpful if this information could be included in future weekly Yellow card publications.

Yours faithfully,

J.Rodgers

MHRA Customer Services, Medicines and Healthcare Products Regulatory Agency

Thank you for your email.  This auto-response is to inform you that your
email has been received and will be reviewed by our Customer Service Team.
We will respond to you as soon as possible. 

 

Please note that we may not respond if your query: 

 

• contains offensive language
• has already been answered in a previous reply to you
• is illegible
• is selling or promoting a product
• is for information only 

 

Medicines and Healthcare products Regulatory Agency
10 South Colonnade, 
Canary Wharf, 
London 
E14 4PU
gov.uk/mhra
Stay connected 
 
For information on how the Agency uses your personal data and your data
protection rights, please see our three centres’ Privacy Notices: MHRA,
CPRD and NIBSC. 

 

The UK has left the EU, and the transition period ends on 31 December
2020. Our [1]guidance and information can be accessed here. 

References

Visible links
1. https://www.gov.uk/government/collection...

MHRA Customer Services, Medicines and Healthcare Products Regulatory Agency

 

 

Our Ref: FOI 21/553

       

Dear J Rodgers,

       

RE:  REQUEST UNDER THE FREEDOM OF INFORMATION ACT 2000

        

Thank you for your enquiry which we received on 24 May 2021.

  

I confirm that your request is now being handled under the Freedom of
Information Act and you should receive a reply within 20 working days from
our date of receipt. 

 

If you need to contact us again about this request, please quote the
reference number above.

 

Please be aware that we publish FOIs replies and these are redacted and
are located on our website at the following link below.

[1]https://www.gov.uk/government/collection...

        

Kind Regards,

 

 

MHRA Customer Service Centre

 

Medicines and Healthcare products Regulatory Agency

10 South Colonnade, Canary Wharf, London E14 4PU

Telephone 0203 080 6000

 

 

 

show quoted sections

Pharmacovigilanceservice, Medicines and Healthcare Products Regulatory Agency

1 Attachment

Dear Ms Rodgers,

Please find attached the response to your FOI request.

Kind regards,

 

FOI Team

Vigilance and Risk Management of Medicines Division

Medicines and Healthcare Products Regulatory Agency
10 South Colonnade, Canary Wharf, London E14 4PU

 

 

 

 

show quoted sections

We don't know whether the most recent response to this request contains information or not – if you are Joanna Rodgers please sign in and let everyone know.